XML 41 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock Option Plan and Stock Based Compensation (Tables)
9 Months Ended
Nov. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Option Activity

The Company had the following stock option activity for the nine months ended November 30, 2018:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

Number

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

of Shares

 

 

Exercise

 

 

Contractual

 

 

Value(a)

 

 

 

(exact quantity)

 

 

Price

 

 

Life (in years)

 

 

(in thousands)

 

Outstanding at March 1, 2018

 

 

172,496

 

 

$

15.95

 

 

 

3.2

 

 

$

612

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Terminated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(110,906

)

 

 

15.99

 

 

 

 

 

 

 

 

 

Outstanding at November 30, 2018

 

 

61,590

 

 

$

15.88

 

 

 

2.1

 

 

$

225

 

Exercisable at November 30, 2018

 

 

61,590

 

 

$

15.88

 

 

 

2.1

 

 

$

225

 

 

(a)

Intrinsic value is measured as the excess of fair market value of the Company’s common stock as reported on the New York Stock Exchange over the applicable exercise price.

Summary of Stock Options Exercised and Tax Benefits Realized from Stock Based Compensation

A summary of the stock options exercised and tax benefits realized from stock based compensation is presented below (in thousands):

 

 

 

Three months ended

 

 

Nine months ended

 

 

 

November 30,

 

 

November 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Total cash received

 

$

 

 

$

 

 

$

69

 

 

 

 

Income tax benefits

 

 

 

 

 

 

 

 

 

 

 

 

Total grant-date fair value

 

 

 

 

 

 

 

 

345

 

 

 

 

Intrinsic value

 

 

 

 

 

 

 

 

534

 

 

 

 

Summary of Unvested Stock Options

 

A summary of the Company’s unvested stock options at November 30, 2018 and the changes during the nine months ended November 30, 2018 are presented below:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number

 

 

Grant Date

 

 

 

of Options

 

 

Fair Value

 

Unvested at March 1, 2018

 

 

1,616

 

 

$

2.24

 

New grants

 

 

 

 

 

 

Vested

 

 

(1,616

)

 

 

2.24

 

Forfeited

 

 

 

 

 

 

Unvested at November 30, 2018

 

 

 

 

 

 

Restricted Stock Grant Activity

The Company had the following restricted stock grant activity for the nine months ended November 30, 2018:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Outstanding at March 1, 2018

 

 

152,675

 

 

$

16.59

 

Granted

 

 

83,789

 

 

 

20.54

 

Terminated

 

 

 

 

 

 

Vested

 

 

(80,692

)

 

 

16.02

 

Outstanding at November 30, 2018

 

 

155,772

 

 

$

19.01